FDA Adverse Event Other Summary report: N

ADVIA 120/2120

MDR report key: 690220 · Received March 17, 2006

Report

Report Number
2432235-2006-00001
Event Type
Other
Date Received
March 17, 2006
Date of Event
February 20, 2006
Report Date
February 22, 2006
Manufacturer
BAYER DIAGNOSTICS MFG. LTD.
Product Code
GKZ
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 1

IN 2006 IT WAS REPORTED THAT A PT SAMPLE RUN ON THE ADVIA 120/2120 GAVE AN HGB RESULT OF 5.2 G/DL. EVEN THOUGH THE SYSTEM FLAGGED THIS RESULT WITH A 'CC' CODE (WHICH ALERTS THE USER TO REVEIW THE RESULTS AND TAKE APPROPRIATE ACTION), THE TECHNOLOGIST RELEASED THE RESULT TO THE PHYSIIAN AND THE PT RECEIVED A BLOOD TRANSFUSION. UPON FURTHER DISCUSSION WITH THE CUSTOMER, THEY ACKNOWLEDGED THAT THE INITIAL RESULT WAS FLAGGED AND THE TECH SHOULD HAVE REPEATED THE SAMPLE AT THAT TIME TO VERIFY THE RESULTS. SUBSEQUENT TESTING OF THE ORIGINAL SAMPLE 3 DAYS LATER, GAVE A HGB RESULT OF 11.0G/DL. THE CORPUSCULAR HEMOGLOBIN CONCENTRATION MEAN (CHCM) AND MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC) BOTH PROVIDE A MEASUREMENT OF THE AVERAGE CORPUSCULAR HEMOGLOBIN CONCENTRATION IN THE SAMPLE. THE CHCM IS A DIRECTLY MEASURE PARAMETER BASED ON CELL BY CELL ANALUSIS, WHILE THE MCHC IS A CALCULATED PARAMETER BASED ON HGB, MCV AND RBC RESULTS. IF THEY DIFFER BY MORE THAN 1.9 G/DL, A COMPARISON ERROR MCHC/CHCM (CHCMCE) SAMPLE/SYSTEM FLAG ALERTS OPERATORS TO A CONDITION THAT COULD BE AFFECTING ONE OR MORE OF THE THREE RESULTS (RBC, MCV, OR HGB) USED TO CALCULATE MCHC. DOCUMENTATION IN THE OPERATORS MANUAL STATES THAT WHENEVER SUCH FLAGS ARE TRIGGERED,THE USER SHOULD REVIEW THE RESULTS AND TAKE APPROPRIATE ACTION. FOR MED DEVICE REPORTING PURPOSES THIS EVENT IS CONSIDERED CLOSED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ADVIA 120/2120 HEMATOLOGY SYSTEM GKZ BAYER DIAGNOSTICS MFG. LTD. ADVIA 120/2120 *

Patients

Seq Age Sex Outcome Treatment
1 UNKNOWN Other